Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.95
ROCKWELL MEDICAL, INC. reported 2023 results: revenue between $82.0 million and $86.0 million. Guidance raised.
- Period
- 2023
- Revenue
- between $82.0 million and $86.0 million
- Guidance
- raised
- Result
- guidance update
Exact text from the filing
Rockwell Medical increases its 2023 revenue guidance to between $82.0 million and $86.0 million.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ROCKWELL MEDICAL, INC. entered into Asset Purchase Agreement with Evoqua Water Technologies LLC valued at $11,000,000 in cash paid at Closing and equal annual installments of $2,500,000 (effective 2023-07-10).
- Action
- entry
- Agreement
- asset purchase
- Counterparty
- Evoqua Water Technologies LLC
- Value
- $11,000,000 in cash paid at Closing and equal annual installments of $2,500,000
- Effective
- 2023-07-10
Exact text from the filing
On July 10, 2023, Rockwell Medical, Inc. (the “Company”) executed and consummated the transactions contemplated by an Asset Purchase Agreement (the “Purchase Agreement”) with Evoqua Water Technologies LLC, a Delaware limited liability company (“Evoqua”).
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
ROCKWELL MEDICAL, INC. entered into Letter Agreement with Armistice Capital Master Fund Ltd. valued at approximately $13.8 million (effective 2023-07-10).
- Action
- entry
- Agreement
- equity purchase
- Counterparty
- Armistice Capital Master Fund Ltd.
- Value
- approximately $13.8 million
- Effective
- 2023-07-10
Exact text from the filing
On July 10, 2023, the Company entered into a letter agreement (the “Letter Agreement”) with Armistice Capital Master Fund Ltd. (“Armistice”), which held a warrant (the “Prior Warrant”) to purchase 9,900,990 shares of common stock of the Company (the “Common Stock”) with an exercise price of $1.39 per share, offering Armistice the opportunity to exercise the Prior Warrant for cash, provided the Prior Warrant was exercised for cash on or prior to 5:00 P.M. Eastern Time on July 10, 2028 (the “End Date”).
View on SEC.gov